|
May 14
|
Will Insulet's Monopoly Crumble? Appellate Court Ruling Signals Shift in Automated Insulin Delivery Systems Market
|
|
May 14
|
Wall Street Trades Flat On Mixed Producer Inflation; Meme Stocks See Wild Ride, Bitcoin Drops: What's Driving Markets Tuesday?
|
|
May 13
|
Insulet (PODD) Q1 Earnings Top, 2024 Revenue View Raised
|
|
May 12
|
Results: Insulet Corporation Beat Earnings Expectations And Analysts Now Have New Forecasts
|
|
May 10
|
Insulet Corporation (NASDAQ:PODD) Q1 2024 Earnings Call Transcript
|
|
May 10
|
Insulet Corp (PODD) Reports Strong Q1 2024 Results and Raises Full-Year Guidance
|
|
May 9
|
Here's What Key Metrics Tell Us About Insulet (PODD) Q1 Earnings
|
|
May 9
|
Insulet Reports First Quarter 2024 Revenue Increase of 23% Year-Over-Year
|
|
May 9
|
Nvidia, Micron and Super Micro among companies that shine in Wall Street’s ‘beat-and-raise’ game
|
|
May 7
|
Insulet’s 2023 Sustainability Report Highlights Commitment to Product Accessibility and Responsible Growth
|
|
May 6
|
Gear Up for Insulet (PODD) Q1 Earnings: Wall Street Estimates for Key Metrics
|
|
May 2
|
Insulet (PODD) Rises Higher Than Market: Key Facts
|
|
May 2
|
Why Insulet (PODD) is a Top Momentum Stock for the Long-Term
|
|
Apr 28
|
American Politicians are Selling These 10 Stocks
|
|
Apr 26
|
Insulet (PODD) Outperforms Broader Market: What You Need to Know
|
|
Apr 24
|
Insulet (PODD) Awaits Q1 Earnings Release: Here's What to Expect
|
|
Apr 19
|
5 Large-Cap Medical Stocks to Buy Ahead of Q1 Earnings
|
|
Apr 18
|
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
|
|
Apr 17
|
Abbott (ABT) Q1 Earnings Beat Estimates, Margins Contract
|
|
Apr 17
|
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
|